Global Argatroban Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2027

  • Report Code : WMR256241
  • Pages : 121
  • Published On : Feb 2019
  • Industry : Healthcare and Pharmaceuticals
  • Format :

Choose License Type

Single User License: US$ 3,480
Multi User License: US$ 5,220
Corporate User License: US$ 6,960
Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.

Scope of the Report:
In the last several years, global market of Argatroban Industry decreased with the average production growth rate about -15%. In 2015, global capacity of Argatroban reduced to 34786 grams
from 65183 grams since 2011. It is predicted that the argatroban demand will continue to decrease with a average growth rate of -9% in the coming five years.

Japan is the still largest supplier of argatroban with the production market share of 35% and the consumption market share of 22% in 2015.

The price of argatroban is relatively expensive. The largest consumers are developed countries with high income. USA occupied a market share of 34%. The second place is Europe, following North America with the consumption market share of 22% in 2015.

China has few companies entering the market with production share of only 8%, and demand cannot be satisfied with supply. Large quantities of argatroban have to be imported.

Intially, compared with hirudin and heparin, the therapeutic dose has little effect on platelet, no antigen and strong antithrombotic effect. The sale value has reached 190 million USA dollars in 2008. But because of its narrow therapeutic area, uncertain factors on human's bodies and fierce competition from other substitutes, it sales far less than other thrombin inhibitor. The value reduced to 101 million USA dollars in 2015.

The worldwide market for Argatroban is expected to grow at a CAGR of roughly -14.9% over the next five years, will reach 32 million US$ in 2024, from 84 million US$ in 2019, according to a new WMR study.
This report focuses on the Argatroban in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Pfizer, Inc
SANDOZ
GlaxoSmithKline Plc
fresenius-kabi
Eagle Pharmaceuticals, Inc
Mitsubishi Tanabe Pharma
Teva Pharmaceutical Industries Ltd
WEST-WARD,INC

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Argatroban Powder
Argatroban Injection

Market Segment by Applications, can be divided into
Heparin-induced thrombocytopenia (HIT)
Percutaneous Coronary Intervention
Cerebral arterial thrombosis

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Argatroban product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Argatroban, with price, sales, revenue and global market share of Argatroban in 2017 and 2018.
Chapter 3, the Argatroban competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Argatroban breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Argatroban market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Argatroban sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents

1 Market Overview
1.1 Argatroban Introduction
1.2 Market Analysis by Type
1.2.1 Argatroban Powder
1.2.2 Argatroban Injection
1.3 Market Analysis by Applications
1.3.1 Heparin-induced thrombocytopenia (HIT)
1.3.2 Percutaneous Coronary Intervention
1.3.3 Cerebral arterial thrombosis
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer, Inc
2.1.1 Business Overview
2.1.2 Argatroban Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer, Inc Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 SANDOZ
2.2.1 Business Overview
2.2.2 Argatroban Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 SANDOZ Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 GlaxoSmithKline Plc
2.3.1 Business Overview
2.3.2 Argatroban Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 GlaxoSmithKline Plc Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 fresenius-kabi
2.4.1 Business Overview
2.4.2 Argatroban Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 fresenius-kabi Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Eagle Pharmaceuticals, Inc
2.5.1 Business Overview
2.5.2 Argatroban Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Eagle Pharmaceuticals, Inc Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Mitsubishi Tanabe Pharma
2.6.1 Business Overview
2.6.2 Argatroban Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Mitsubishi Tanabe Pharma Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Teva Pharmaceutical Industries Ltd
2.7.1 Business Overview
2.7.2 Argatroban Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Teva Pharmaceutical Industries Ltd Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 WEST-WARD,INC
2.8.1 Business Overview
2.8.2 Argatroban Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 WEST-WARD,INC Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Argatroban Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Argatroban Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Argatroban Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Argatroban Manufacturer Market Share in 2018
3.3.2 Top 6 Argatroban Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Argatroban Market Analysis by Regions
4.1 Global Argatroban Sales, Revenue and Market Share by Regions
4.1.1 Global Argatroban Sales and Market Share by Regions (2014-2019)
4.1.2 Global Argatroban Revenue and Market Share by Regions (2014-2019)
4.2 North America Argatroban Sales and Growth Rate (2014-2019)
4.3 Europe Argatroban Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Argatroban Sales and Growth Rate (2014-2019)
4.5 South America Argatroban Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Argatroban Sales and Growth Rate (2014-2019)
5 North America Argatroban by Country
5.1 North America Argatroban Sales, Revenue and Market Share by Country
5.1.1 North America Argatroban Sales and Market Share by Country (2014-2019)
5.1.2 North America Argatroban Revenue and Market Share by Country (2014-2019)
5.2 United States Argatroban Sales and Growth Rate (2014-2019)
5.3 Canada Argatroban Sales and Growth Rate (2014-2019)
5.4 Mexico Argatroban Sales and Growth Rate (2014-2019)
6 Europe Argatroban by Country
6.1 Europe Argatroban Sales, Revenue and Market Share by Country
6.1.1 Europe Argatroban Sales and Market Share by Country (2014-2019)
6.1.2 Europe Argatroban Revenue and Market Share by Country (2014-2019)
6.2 Germany Argatroban Sales and Growth Rate (2014-2019)
6.3 UK Argatroban Sales and Growth Rate (2014-2019)
6.4 France Argatroban Sales and Growth Rate (2014-2019)
6.5 Russia Argatroban Sales and Growth Rate (2014-2019)
6.6 Italy Argatroban Sales and Growth Rate (2014-2019)
7 Asia-Pacific Argatroban by Country
7.1 Asia-Pacific Argatroban Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Argatroban Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Argatroban Revenue and Market Share by Country (2014-2019)
7.2 China Argatroban Sales and Growth Rate (2014-2019)
7.3 Japan Argatroban Sales and Growth Rate (2014-2019)
7.4 Korea Argatroban Sales and Growth Rate (2014-2019)
7.5 India Argatroban Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Argatroban Sales and Growth Rate (2014-2019)
8 South America Argatroban by Country
8.1 South America Argatroban Sales, Revenue and Market Share by Country
8.1.1 South America Argatroban Sales and Market Share by Country (2014-2019)
8.1.2 South America Argatroban Revenue and Market Share by Country (2014-2019)
8.2 Brazil Argatroban Sales and Growth Rate (2014-2019)
8.3 Argentina Argatroban Sales and Growth Rate (2014-2019)
8.4 Colombia Argatroban Sales and Growth Rate (2014-2019)
9 Middle East and Africa Argatroban by Countries
9.1 Middle East and Africa Argatroban Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Argatroban Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Argatroban Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Argatroban Sales and Growth Rate (2014-2019)
9.3 Turkey Argatroban Sales and Growth Rate (2014-2019)
9.4 Egypt Argatroban Sales and Growth Rate (2014-2019)
9.5 Nigeria Argatroban Sales and Growth Rate (2014-2019)
9.6 South Africa Argatroban Sales and Growth Rate (2014-2019)
10 Global Argatroban Market Segment by Type
10.1 Global Argatroban Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Argatroban Sales and Market Share by Type (2014-2019)
10.1.2 Global Argatroban Revenue and Market Share by Type (2014-2019)
10.2 Argatroban Powder Sales Growth and Price
10.2.1 Global Argatroban Powder Sales Growth (2014-2019)
10.2.2 Global Argatroban Powder Price (2014-2019)
10.3 Argatroban Injection Sales Growth and Price
10.3.1 Global Argatroban Injection Sales Growth (2014-2019)
10.3.2 Global Argatroban Injection Price (2014-2019)
11 Global Argatroban Market Segment by Application
11.1 Global Argatroban Sales Market Share by Application (2014-2019)
11.2 Heparin-induced thrombocytopenia (HIT) Sales Growth (2014-2019)
11.3 Percutaneous Coronary Intervention Sales Growth (2014-2019)
11.4 Cerebral arterial thrombosis Sales Growth (2014-2019)
12 Argatroban Market Forecast (2019-2024)
12.1 Global Argatroban Sales, Revenue and Growth Rate (2019-2024)
12.2 Argatroban Market Forecast by Regions (2019-2024)
12.2.1 North America Argatroban Market Forecast (2019-2024)
12.2.2 Europe Argatroban Market Forecast (2019-2024)
12.2.3 Asia-Pacific Argatroban Market Forecast (2019-2024)
12.2.4 South America Argatroban Market Forecast (2019-2024)
12.2.5 Middle East and Africa Argatroban Market Forecast (2019-2024)
12.3 Argatroban Market Forecast by Type (2019-2024)
12.3.1 Global Argatroban Sales Forecast by Type (2019-2024)
12.3.2 Global Argatroban Market Share Forecast by Type (2019-2024)
12.4 Argatroban Market Forecast by Application (2019-2024)
12.4.1 Global Argatroban Sales Forecast by Application (2019-2024)
12.4.2 Global Argatroban Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source


List of Tables and Figures

Figure Argatroban Picture
Table Product Specifications of Argatroban
Figure Global Sales Market Share of Argatroban by Types in 2018
Table Argatroban Types for Major Manufacturers
Figure Argatroban Powder Picture
Figure Argatroban Injection Picture
Figure Argatroban Sales Market Share by Applications in 2018
Figure Heparin-induced thrombocytopenia (HIT) Picture
Figure Percutaneous Coronary Intervention Picture
Figure Cerebral arterial thrombosis Picture
Figure United States Argatroban Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Argatroban Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Argatroban Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Argatroban Revenue (Value) and Growth Rate (2014-2024)
Figure France Argatroban Revenue (Value) and Growth Rate (2014-2024)
Figure UK Argatroban Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Argatroban Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Argatroban Revenue (Value) and Growth Rate (2014-2024)
Figure China Argatroban Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Argatroban Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Argatroban Revenue (Value) and Growth Rate (2014-2024)
Figure India Argatroban Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Argatroban Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Argatroban Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Argatroban Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Argatroban Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Argatroban Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Argatroban Revenue (Value) and Growth Rate (2014-2024)
Table Pfizer, Inc Basic Information, Manufacturing Base and Competitors
Table Pfizer, Inc Argatroban Type and Applications
Table Pfizer, Inc Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table SANDOZ Basic Information, Manufacturing Base and Competitors
Table SANDOZ Argatroban Type and Applications
Table SANDOZ Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Plc Argatroban Type and Applications
Table GlaxoSmithKline Plc Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table fresenius-kabi Basic Information, Manufacturing Base and Competitors
Table fresenius-kabi Argatroban Type and Applications
Table fresenius-kabi Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Eagle Pharmaceuticals, Inc Basic Information, Manufacturing Base and Competitors
Table Eagle Pharmaceuticals, Inc Argatroban Type and Applications
Table Eagle Pharmaceuticals, Inc Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table Mitsubishi Tanabe Pharma Argatroban Type and Applications
Table Mitsubishi Tanabe Pharma Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Industries Ltd Argatroban Type and Applications
Table Teva Pharmaceutical Industries Ltd Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table WEST-WARD,INC Basic Information, Manufacturing Base and Competitors
Table WEST-WARD,INC Argatroban Type and Applications
Table WEST-WARD,INC Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Argatroban Sales by Manufacturer (2017-2018)
Figure Global Argatroban Sales Market Share by Manufacturer in 2017
Figure Global Argatroban Sales Market Share by Manufacturer in 2018
Table Global Argatroban Revenue by Manufacturer (2017-2018)
Figure Global Argatroban Revenue Market Share by Manufacturer in 2017
Figure Global Argatroban Revenue Market Share by Manufacturer in 2018
Figure Top 3 Argatroban Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Argatroban Manufacturer (Revenue) Market Share in 2018
Figure Global Argatroban Sales and Growth Rate (2014-2019)
Figure Global Argatroban Revenue and Growth Rate (2014-2019)
Table Global Argatroban Sales by Regions (2014-2019)
Table Global Argatroban Sales Market Share by Regions (2014-2019)
Table Global Argatroban Revenue by Regions (2014-2019)
Figure Global Argatroban Revenue Market Share by Regions in 2014
Figure Global Argatroban Revenue Market Share by Regions in 2018
Figure North America Argatroban Sales and Growth Rate (2014-2019)
Figure Europe Argatroban Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Argatroban Sales and Growth Rate (2014-2019)
Figure South America Argatroban Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Argatroban Sales and Growth Rate (2014-2019)
Figure North America Argatroban Revenue and Growth Rate (2014-2019)
Table North America Argatroban Sales by Countries (2014-2019)
Table North America Argatroban Sales Market Share by Countries (2014-2019)
Figure North America Argatroban Sales Market Share by Countries in 2014
Figure North America Argatroban Sales Market Share by Countries in 2018
Table North America Argatroban Revenue by Countries (2014-2019)
Table North America Argatroban Revenue Market Share by Countries (2014-2019)
Figure North America Argatroban Revenue Market Share by Countries in 2014
Figure North America Argatroban Revenue Market Share by Countries in 2018
Figure United States Argatroban Sales and Growth Rate (2014-2019)
Figure Canada Argatroban Sales and Growth Rate (2014-2019)
Figure Mexico Argatroban Sales and Growth Rate (2014-2019)
Figure Europe Argatroban Revenue and Growth Rate (2014-2019)
Table Europe Argatroban Sales by Countries (2014-2019)
Table Europe Argatroban Sales Market Share by Countries (2014-2019)
Table Europe Argatroban Revenue by Countries (2014-2019)
Figure Europe Argatroban Revenue Market Share by Countries in 2017
Figure Europe Argatroban Revenue Market Share by Countries in 2018
Figure Germany Argatroban Sales and Growth Rate (2014-2019)
Figure UK Argatroban Sales and Growth Rate (2014-2019)
Figure France Argatroban Sales and Growth Rate (2014-2019)
Figure Russia Argatroban Sales and Growth Rate (2014-2019)
Figure Italy Argatroban Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Argatroban Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Argatroban Sales by Countries (2014-2019)
Table Asia-Pacific Argatroban Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Argatroban Sales Market Share by Countries 2018
Table Asia-Pacific Argatroban Revenue by Countries (2014-2019)
Figure Asia-Pacific Argatroban Revenue Market Share by Countries 2018
Figure China Argatroban Sales and Growth Rate (2014-2019)
Figure Japan Argatroban Sales and Growth Rate (2014-2019)
Figure Korea Argatroban Sales and Growth Rate (2014-2019)
Figure India Argatroban Sales and Growth Rate (2014-2019)
Figure Southeast Asia Argatroban Sales and Growth Rate (2014-2019)
Figure South America Argatroban Revenue and Growth Rate (2014-2019)
Table South America Argatroban Sales by Countries (2014-2019)
Table South America Argatroban Sales Market Share by Countries (2014-2019)
Figure South America Argatroban Sales Market Share by Countries in 2018
Table South America Argatroban Revenue by Countries (2014-2019)
Table South America Argatroban Revenue Market Share by Countries (2014-2019)
Figure South America Argatroban Revenue Market Share by Countries in 2018
Figure Brazil Argatroban Sales and Growth Rate (2014-2019)
Figure Argentina Argatroban Sales and Growth Rate (2014-2019)
Figure Colombia Argatroban Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Argatroban Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Argatroban Sales by Countries (2014-2019)
Table Middle East and Africa Argatroban Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Argatroban Sales Market Share by Countries in 2018
Table Middle East and Africa Argatroban Revenue by Countries (2014-2019)
Table Middle East and Africa Argatroban Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Argatroban Revenue Market Share by Countries in 2014
Figure Middle East and Africa Argatroban Revenue Market Share by Countries in 2018
Figure Saudi Arabia Argatroban Sales and Growth Rate (2014-2019)
Figure UAE Argatroban Sales and Growth Rate (2014-2019)
Figure Egypt Argatroban Sales and Growth Rate (2014-2019)
Figure Nigeria Argatroban Sales and Growth Rate (2014-2019)
Figure South Africa Argatroban Sales and Growth Rate (2014-2019)
Table Global Argatroban Sales by Type (2014-2019)
Table Global Argatroban Sales Share by Type (2014-2019)
Table Global Argatroban Revenue by Type (2014-2019)
Table Global Argatroban Revenue Share by Type (2014-2019)
Figure Global Argatroban Powder Sales Growth (2014-2019)
Figure Global Argatroban Powder Price (2014-2019)
Figure Global Argatroban Injection Sales Growth (2014-2019)
Figure Global Argatroban Injection Price (2014-2019)
Table Global Argatroban Sales by Application (2014-2019)
Table Global Argatroban Sales Share by Application (2014-2019)
Figure Global Percutaneous Coronary Intervention Sales Growth (2014-2019)
Figure Global Cerebral arterial thrombosis Sales Growth (2014-2019)
Figure Global Argatroban Sales, Revenue and Growth Rate (2019-2024)
Table Global Argatroban Sales Forecast by Regions (2019-2024)
Table Global Argatroban Market Share Forecast by Regions (2019-2024)
Figure North America Sales Argatroban Market Forecast (2019-2024)
Figure Europe Sales Argatroban Market Forecast (2019-2024)
Figure Asia-Pacific Sales Argatroban Market Forecast (2019-2024)
Figure South America Sales Argatroban Market Forecast (2019-2024)
Figure Middle East and Africa Sales Argatroban Market Forecast (2019-2024)
Table Global Argatroban Sales Forecast by Type (2019-2024)
Table Global Argatroban Market Share Forecast by Type (2019-2024)
Table Global Argatroban Sales Forecast by Application (2019-2024)
Table Global Argatroban Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List

2022-2027 Global and Regional Argatroban Industry Status and Prospects Professional Market Research Report Standard Version...

The global Argatroban market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2022 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field eva...

Global Argatroban Anhydrous Market Research Report 2022-2026...

The anhydrous form of argatroban, a synthetic derivative of L-arginine with antithrombotic activity. Argatroban is a univalent and direct inhibitor of fibrin-bound thrombin. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this mark...

Global and Japan Argatroban Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2029...

Overview of the Global Argatroban Market:The report discusses everything a marketer requires before investing in the global Argatroban Market during the forecast period 2022-2029. It provides detailed insight into current trends, market shares, market size, and sales value...

(COVID Version) Global Argatroban Market Status (2016-2020) and Forecast (2021E-2026F) by Region, Product Type & End-Use...

Summary Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of ...

2021-2027 Global and Regional Argatroban Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report Standard Version...

The research team projects that the Argatroban market size will grow from XXX in 2020 to XXX by 2027, at an estimated CAGR of XX. The base year considered for the study is 2020, and the market size is projected from 2020 to 2027. The prime objective of this report is to help the user unders...

Argatroban Market Status and Trend Analysis 2017-2026 (COVID-19 Version)...

Summary Further key aspects of the report indicate that: Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology Chapter 2: Global Industry Summary Chapter 3: Market Dynamics Chapter 4: Global Market Segmentation by region, type and End-Use...

COVID-19 Global & China Argatroban Market Research by Company, Type & Application 2015-2026...

Summary Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of ...

Global Argatroban Market Analysis 2016-2020 and Forecast 2021-2026...

Snapshot Application lifecycle management is the process of managing an app's development, from design to final release, and establishing a framework for managing changes. The typical application lifecycle starts with the design of a new app or feature. The app is planned based on requi...

(COVID-19 Version) Global Argatroban Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use...

Summary Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of ...

2015-2025 Global Argatroban Market Research by Type, End-Use and Region (COVID-19 Version)...

Summary Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of ...